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A number of hereditary conditions have been identified
that predispose to colorectal cancer. Most inherited forms
of colorectal cancer can be placed into two groups, those
that are associated with a pre-malignant phenotype (the
“polyposis” syndromes) and those do not have a pre-malig-
nant phenotype (generally termed “non-polyposis”). The
polyposis syndromes can be further subdivided into two
groups; the hamartomatous polyposis syndromes that
include Peutz-Jeghers syndrome (PJS), Cowdens’ syn-
drome (PTEN), juvenile polyposis (JPS) and Ruvalcaba-
Myhre-Smith syndrome (RMSS): and the adenomatous
polyposis syndromes that include familial adenomatous
polyposis, Gardners’ syndrome, Oldfields’ syndrome
Turcot syndrome, Carroli’s Disease and MUTYH asso-
ciated polyposis. The non-polyposis group comprises
Lynch syndrome, Muir-Torre’s syndrome and Turcot syn-
drome (there are two forms of Turcot syndrome, one
relating to familial adenomatous polyposis and the other
to Lynch syndrome).
The genetic basis of the syndromes listed has revealed
disease heterogeneity in the non-polyposis group, where
all these syndromes are associated with errors in DNA
mismatch repair genes (MSH2, MLH1, MSH6 and PMS2).
With respect to the adenomatous polyposis syndromes
most are associated with mutations in the APC gene, the
exception being MUTYH associated polyposis which has
been linked to mutations in MUTYH. There are several
genes that have been linked to the hamartomatous syn-
dromes, STK11 (LKB1) has been shown to be associated
with PJS; PTEN, SMAD4 and BMPR1A with JPS and
RMSS and JPS.
Variance in disease expression can not be accounted
solely by mutations in the respective gene. Differences
between and within families harbouring the same
mutation suggest that other factors are likely to influ-
ence disease risk. In the case of Lynch syndrome it is
now becoming clear that a series of modifier genes are
linked to the age of disease onset and further, the num-
ber of modifier risk alleles appears to increase disease
severity. Recent evidence suggests that two modifiers of
particular interest, located on chromosomes 8 and 11
significantly influence disease onset in MLH1 mutation
carriers.
Knowledge about modifier genes and how they impact
on disease expression is important for improving perso-
nalized patient care, especially in the setting of life-long
surveillance and the potential use of significant prophy-
lactic measures to reduce disease risk.
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